Observation of effect of dexmedetomidine when given intravenously to the pediatric patients undergoing levobupivacaine spinal anaesthesia.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- good health.
- Registration Number
- CTRI/2017/12/010744
- Lead Sponsor
- Department of anaesthesia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
1) class-1 and class-2 patients
2) lower abdominal surgery
3) 2 year to 12 year age
Exclusion Criteria
1) patients refusal.
2) contraindication for spinal anaesthesia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intravenous dexmedetomidine prolong the effect of bupivacaine spinal anaesthesiaTimepoint: end of clinical trial
- Secondary Outcome Measures
Name Time Method provide haemodynamic stability. <br/ ><br>provide good intraoperative sedation and pain free period during operation and postoperative periodTimepoint: end of clinical trial